Glaukos Liabilities 2024

Glaukos Aktienanalyse

What does Glaukos do?

Glaukos Corp is a medical technology company specializing in developing devices and therapies for treating eye diseases. It was founded in 1998 by employees of the ophthalmology center at the University of California San Francisco. The company focuses on utilizing new technologies and therapies to improve the vision quality of patients. They have developed innovative products for diagnosing and treating various eye conditions, including glaucoma. Their core business involves manufacturing and distributing medical devices for glaucoma treatment, such as the iStent implant. They have also partnered with other institutions to advance research and development in the field of ophthalmology. In 2018, Glaukos Corp acquired the German manufacturer Markt II Medical, expanding their product offerings for a wider range of eye diseases. In summary, Glaukos Corp is an innovative medical technology company that aims to enhance patients' vision quality while minimizing the risks of eye surgery. Glaukos ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Glaukos's Liabilities

Glaukos's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Glaukos's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Glaukos's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Glaukos's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Glaukos’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Glaukos stock

What is the level of liabilities of Glaukos this year?

Glaukos has a debt balance of 478.65 M USD this year.

What were the liabilities of Glaukos compared to the previous year?

The liabilities of Glaukos have increased by 1.32% increased compared to the previous year.

What are the consequences of high debt for investors of Glaukos?

High liabilities can pose a risk for investors of Glaukos, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Glaukos?

Low liabilities mean that Glaukos has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Glaukos affect the company?

An increase in liabilities of Glaukos can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Glaukos affect the company?

A decrease in the liabilities of Glaukos can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Glaukos?

Some factors that can influence the liabilities of Glaukos include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Glaukos so important for investors?

The liabilities of Glaukos are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Glaukos take to modify the liabilities?

To change its liabilities, Glaukos can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Glaukos pay?

Over the past 12 months, Glaukos paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Glaukos is expected to pay a dividend of 0 USD.

What is the dividend yield of Glaukos?

The current dividend yield of Glaukos is .

When does Glaukos pay dividends?

Glaukos pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Glaukos?

Glaukos paid dividends every year for the past 0 years.

What is the dividend of Glaukos?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Glaukos located?

Glaukos is assigned to the 'Health' sector.

Wann musste ich die Aktien von Glaukos kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Glaukos from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Glaukos pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Glaukos in the year 2023?

In the year 2023, Glaukos distributed 0 USD as dividends.

In which currency does Glaukos pay out the dividend?

The dividends of Glaukos are distributed in USD.